St. Luke’s Cataract & Laser Institute, founded in 1968 by Dr. James Gills, is a renowned health care institution known for its pioneering work in cataract and laser surgery. It has been a leader in setting industry standards and is dedicated to providing world-class eye care with a personal touch. The institute offers a wide range of clinical care and surgical procedures, including retinal surgery, glaucoma treatment, and cosmetic surgery, all performed at its United States headquarters. With a focus on maintaining the highest standards while keeping costs low, St. Luke’s operates a 78,000-square-foot freestanding clinic and surgical center, attracting patients from over 75 countries. Its self-contained ambulatory surgical center enables efficiency and cost savings, allowing for up to 35% reduction in expenses compared to hospital settings. The institute's commitment to excellence is evident through the dedication of its staff and its ongoing pursuit of innovative and cost-effective care. For venture capital organizations seeking potential investment opportunities in the health care sector, St. Luke’s Cataract & Laser Institute stands out as a leader with a strong track record of innovation, global recognition, and a patient-centric approach.
There is no investment information
No recent news or press coverage available for St. Luke's Cataract & Laser Institute.